Related Experiment Videos

Providers' AHCA worries rise after latest CBO analysis

Mara Lee, Matthew Weinstock

Modern Healthcare

|November 28, 2018

Abstract:

The Congressional Budget Office estimated that 23 million people would lose health coverage by 2026 under the American Health Care Act.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.

The Lancet. Oncology·2021

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model.

Haematologica·2021

Double-Hit and Triple-Hit Follicular Lymphoma.

American journal of clinical pathology·2020

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.

British journal of haematology·2019

Questions raised over AHCA's impact on protections for veterans.

Modern healthcare·2018

See all related articles